The emergence of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable interest within the weight loss community. This novel dual GIP and GLP-1 receptor medication suggests to provide notable improvements in weight shedding compared to previous therapies. Initial clinical trials have s